News
TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure (HF), today announced results of VECTOR-HF I ...
The results of the VECTOR-HF I study will be presented at the prestigious Late-Breaking Trials session during the European Society of Cardiology Heart Failure 2022 conference in Madrid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results